JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for GP-UK Archives


GP-UK Archives

GP-UK Archives


GP-UK@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

GP-UK Home

GP-UK Home

GP-UK  1998

GP-UK 1998

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: leukotriene inhibitor for asthma

From:

[log in to unmask] (Mark Pownall)

Reply-To:

[log in to unmask]

Date:

Thu, 26 Feb 1998 09:09:42 +0100

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (78 lines)


Douglas Soutter wrote
>Yes - but it is being promoted as an ADD ON to steroids if these are not
>controlling your asthma (which make a change from how Salmeterol started).
>They also appear to be less effective than standard doses of steroids from
>what I have manged to read of them.  Why have all the patients I saw (well
>only two) with newspaper clippings think that they were going to
>revolutionise their asthma and also get them off their steroids.  I thought
>reporters were supposed to be skilled at informing.


I can't rmember exactly, but the telly pieces I saw did mention that it
would be used with currently used drugs, and did their best to steer that
difficult line between avoiding the use of inflammatory words like
'revolutionary' and 'breakthrough' and making the story so boring that the
editor spikes it. Perhaps it was your patients hopes, rahter than anything
particualr they read that made them think they could get off steroids?
The clinical details are difficult to put over in a 300 word news story
(with  case history) or a couple of minutes of broadcast team. I expect you
agree with me that hacks  should steer clear of saying where a drug should
be used in asthma management.


Andrew Herd wrote:  >The media is manipulated all the time. Many
reporters seem to be unaware of the fact that the pharmaceuticals get pretty
stroppy if knocking copy is written, and will withdraw advertising. Since
the editors/owners depend on the advertising for profits, a de facto
censorship of copy occurs. This is effect is quite powerful.
The drug companies spend at least 10k per annum per GP on adverts, in one of
the most successful attempts to influence target behaviour (i.e. GP
prescribing) ever mounted. I was made acutely aware of this a decade ago
>when I worked with an advertising company.

Hmmm. Depends what you mean by manipulated, I suppose. People write books -
entire series of books - about media priorities, and getting good coverage
in the media. One influence is 'the event' where everyone covers a story
(you don't want to be left out). But that is mostly a matter of emphasis.
The story has to worth doing to attract the attention in the first place.
But there are numerous other influences. I think that hype rarely puts a
non-story in a medical newspaper, although skilful PR can give an average
story more prominence than  it perhaps deserves. I would not consider that
we are manipulated all the time, any more than GPs would think they are
manipulated all the time by their patients. They might try, but it does not
always work.
Of course hacks are aware that pharmaceutical companies pay for the ads in
medical newspapers, and can kick up a fuss if they do not liek what is
written. I can't speak about the current GP tabloids because I haven't
worked in house for them for a while. When I did, there was no censorship
of copy if we wrote fair and balanced stories about side-effects of drugs.
Advertisers did threaten to withdraw advertising, and in one case I
remember, actually did. But  The main criterion was it had to be a drug
which GPs commonly prescribed.
If a pharmaceutical company complained about an accurate and fair story, we
would consider that we had done a good job. If there were inaccuracies, or
the full story had not been told because of pressure sof time and editorial
space, a follow up story might be thoght worthwhile, or the medical
director of the company might be invited to offer a letter for publication
in the letters column.
The GP press sells its ads largely on the back of the proportion of regular
GP readers they attract. Publishing history shows that the newspapers and
magazines who write for advertisers rather than readers tend not to do as
well as those whose priority is producing a magazine they think GPs will
read.
The tabloids do seem to have moved away from writing about drugs. The
commercial reason may be that GPs want to read about other things more, or
it may be a case that upsetting advertisers once in a while is more trouble
than it is worth. I do not know. You could ask them, but I don't think they
would tell you.


Apologies for the long posting. I had better get back to writing some words
that will make me some money....




%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

March 2024
October 2023
August 2023
June 2023
May 2023
February 2023
June 2022
October 2021
January 2021
October 2020
September 2020
August 2020
July 2020
June 2020
March 2020
January 2020
December 2019
September 2019
July 2019
June 2019
May 2019
March 2019
February 2019
January 2019
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
March 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager